F-star Therapeutics FSTX
$ 7.12
0.0%
Quarterly report 2022-Q3
added 11-10-2022
Country |
USA |
IPO year |
2016 |
Industry |
- |
Stock Exchange |
NASDAQ CAPITAL |
CEO |
- |
Employees in the company |
- |
Shares |
16.6 M |
Market Cap[1] |
$ 157 M |
EBITDA (LTM) |
$ -49.5 M |
P/E (LTM) |
-2.53 |
P/S (LTM) |
21.28 |
EPS (LTM) |
-2.81 |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.